Global Primary Cell Culture Market Size By Product (Primary Cell, Reagents And Supplements, Media), By Application (Vaccine Production, Stem Cell Therapy, Cancer Research), By Cell Type (Animal Cells, Human Cells), By Geographic Scope And Forecast
일차 세포배양 시장 규모 및 예측
일차 세포배양 시장 규모는 2024년에 45억 3,000만 달러로 평가되었으며, 2026년부터 2032년까지 CAGR 11.37%로 성장하여 2032년에는 107억 1,000만 달러에 달할 것으로 예상됩니다.
- 일차 세포배양은 조직에서 직접 세포를 분리하여 통제된 실험실 조건에서 증식시키는 과정입니다.
- 연구 개발에서 일차 세포배양의 중요성이 커지고 있는 이유는 생체 내 세포의 생리적 거동을 충실하게 모방하여 보다 정확한 연구 모델을 제공할 수 있기 때문입니다.
- 이 방법에서 세포는 일반적으로 살아있는 생물체에서 채취하여 자연 상태에 큰 변화를 주지 않고 배양하기 때문에 중요한 생물학적 특성이 그대로 유지됩니다.
- 일차 세포배양 개발은 신약개발, 독성학, 암 연구, 재생의료 등의 분야에서 증가하고 있으며, 세포의 거동을 연구하고, 치료제를 시험하고, 맞춤형 치료법을 개발하는 데 사용되고 있습니다.
- 보다 정확하고 신뢰할 수 있는 in vitro 모델에 대한 요구가 높아짐에 따라, 연속적인 세포주에 비해 in vivo 조건에 더 가깝다는 점에서 일차 세포의 사용이 더욱 촉진되고 있습니다.
- 배양 중 일차 세포의 증식은 세포의 생존력과 기능을 유지하기 위해 신중하게 조절된 특정 증식 인자와 영양소의 존재를 필요로 합니다.
- 사이토카인이나 호르몬과 같은 성장인자는 이러한 배양에서 세포의 증식, 분화, 생존을 촉진하는 데 필수적입니다.
일차 세포배양 세계 시장 역학
세계 일차 세포배양 시장을 형성하고 있는 주요 시장 역학은 다음과 같습니다:
주요 촉진요인
- 맞춤의료에 대한 수요 증가 : 맞춤의료와 정밀의료에 대한 관심 증가는 환자 맞춤형 치료법 개발에 세포가 필수적이기 때문에 일차 세포배양 시장을 견인할 것으로 예상됩니다. 이 시장은 정확한 시험관 내 모델을 필요로 하는 첨단 의료에 대한 투자가 증가함에 따라 수혜를 받을 것으로 예상됩니다. Personalized Medicine Coalition에 따르면, 개발 중인 맞춤형 의약품의 수는 2017년에서 2022년 사이에 34% 증가하여 286개 이상의 치료법에 도달할 것으로 예상됩니다.
- 신약개발에 대한 관심이 높아짐에 따라, 특히 유효성 및 독성 테스트를 위한 일차 세포배양에 대한 채택이 가속화될 것으로 예상됩니다. 이러한 세포는 보다 신뢰할 수 있는 인간 기반 세포 모델을 제공함으로써 동물 실험에 대한 의존도를 낮추는 데 중요한 역할을 할 것으로 보입니다.
- 암 연구에 대한 투자 : 암 연구에 대한 투자가 높고, 이러한 배양세포는 암세포의 거동 연구에 널리 사용되고 있으며, 이는 일차 세포배양 시장의 활성화로 이어질 것으로 예상됩니다. 전 세계 암 발병률의 증가는 고급 세포 모델에 대한 수요를 증가시켜 시장 성장을 증가시킬 것으로 예상됩니다.
- 3D 세포배양 활용 확대 : 3D 세포배양은 기존 2D 배양보다 생체 내 환경을 더 효과적으로 재현할 수 있기 때문에 연구에 채택되면 일차 세포의 관련성이 높아질 것으로 추정됩니다. 이러한 추세는 다양한 연구 분야에서 일차 세포배양의 적용 범위를 확대할 것으로 예상되며, VMR에 따르면 3D 세포배양 시장 규모는 2022년 18억 8,000만 달러로 2023년부터 2030년까지 10.87%의 CAGR로 2030년에는 43억 달러에 달할 것으로 예측됩니다.
주요 과제
- 일차 세포배양의 높은 비용 : 일차 세포배양 과정과 관련된 높은 비용은 특히 연구 자금이 제한적인 지역에서 시장 성장을 억제할 것으로 예상됩니다. 일차 세포의 조달과 특정 증식 조건을 유지하는 데 드는 비용은 시장 확대에 중요한 과제가 될 것으로 예상됩니다.
- 기술적 복잡성과 가변성 : 일차 세포배양의 기술적 복잡성과 고유한 변동성은 보급에 걸림돌이 될 가능성이 높습니다. 이 문제는 대규모 연구 및 산업 응용에서 확장성과 재현성을 제한할 것으로 예상됩니다.
- 일차 세포의 제한된 가용성 : 배양용 인간 조직 및 동물 조직의 조달이 여전히 어렵기 때문에 고품질 일차 세포의 가용성이 제한적이라는 점이 시장 성장을 저해할 것으로 예상됩니다. 조직 조달과 관련된 윤리적 우려와 규제적 제한이 공급망을 더욱 제약할 것으로 예상됩니다.
- 오염 위험과 짧은 수명 : 불멸화 세포주에 비해 일차 세포는 오염 위험이 높고 수명이 짧아 시장을 억제할 가능성이 높습니다. 이러한 제한으로 인해 실험실 운영상의 어려움이 증가하여 장기 연구의 효율성이 저하될 것으로 예상됩니다.
주요 동향
- 줄기세포 연구에 대한 관심 : 재생의료에서 고품질의 1차 세포가 필요함에 따라 줄기세포 연구가 강조되면서 일차 세포배양 시장에 큰 영향을 미칠 것으로 예상됩니다. 이러한 추세는 생명공학 및 제약 부문 전반의 연구개발에 대한 투자를 강화할 가능성이 높습니다.
- 학계와 산업계의 협력 : 학계와 바이오제약 기업 간의 파트너십 확대는 일차 세포배양 시장을 견인할 것으로 예상됩니다. 이러한 공동 연구는 기술 혁신을 촉진하고 새로운 세포 기반 치료법 및 연구 도구의 상용화를 촉진할 것으로 예상됩니다.
- 첨단 조직공학에 대한 수요 : 첨단 조직공학 솔루션에 대한 높은 수요는 연구 및 임상 응용 분야에서 일차 세포배양의 채택을 촉진할 것으로 예상됩니다. 이러한 추세는 오가노이드 및 바이오 엔지니어링 조직 개발에 새로운 길을 열어 시장 잠재력을 더욱 확대할 것으로 보입니다.
목차
제1장 세계의 일차 세포배양 시장 소개
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH 조사 방법
- 데이터 마이닝
- 검증
- 1차 자료
- 데이터 소스 리스트
제4장 세계의 일차 세포배양 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
제5장 일차 세포배양 세계 시장, 제품별
- 개요
- 일차 세포
- 시약과 보충제
- 세포배양용 배지
제6장 일차 세포배양 세계 시장 : 용도별
제7장 일차 세포배양 세계 시장, 세포 유형별
제8장 일차 세포배양 세계 시장 : 지역별
제9장 세계의 일차 세포배양 시장 경쟁 구도
제10장 기업 개요
- Thermo Fisher Scientific Inc.
- Lonza
- Merck KGaA
- Axol Bioscience Ltd
- GE Healthcare
- STEMCELL Technologies Inc
- Cell Biologics
- ZenBio
- ScienCell Research Laboratories
- PPA Research Group
제11장 주요 발전
- 제품 출시/개발
- 인수합병
- 사업 확대
- 파트너십과 제휴
제12장 부록
ksm
Primary Cell Culture Market Size And Forecast
Primary Cell Culture Market size was valued at USD 4.53 Billion in 2024 and is projected to reach USD 10.71 Billion by 2032, growing at a CAGR of 11.37% from 2026 to 2032.
- Primary cell culture is the process by which cells are isolated directly from tissues and grown under controlled laboratory conditions.
- The growing importance of primary cell culture in research and development is attributed to its ability to closely mimic the physiological behavior of cells within an organism, providing more accurate study models.
- In this method, cells are typically harvested from a living organism and cultured without significant alterations to their natural state, ensuring the retention of critical biological characteristics.
- Applications of primary cell cultures are rising in fields such as drug discovery, toxicology, cancer research, and regenerative medicine, where they are used to study cell behavior, test therapeutic agents, and develop personalized treatments.
- The increasing demand for more precise and reliable in vitro models has further driven the use of primary cells, given their closer resemblance to in vivo conditions compared to continuous cell lines.
- The growth of primary cells in culture requires the presence of specific growth factors and nutrients, which are carefully regulated to maintain cellular viability and function.
- Growth factors, such as cytokines and hormones, are essential for promoting cell proliferation, differentiation, and survival in these cultures.
Global Primary Cell Culture Market Dynamics
The key market dynamics that are shaping the global primary cell culture market include:
Key Drivers:
- Growing Demand for Personalized Medicine: The rising interest in personalized and precision medicine is anticipated to drive the primary cell culture market, as these cells are integral to developing patient-specific therapies. The market is expected to benefit from increasing investments in advanced medical treatments that require accurate in vitro models. According to the Personalized Medicine Coalition, the number of personalized medicines in development increased by 34% between 2017 and 2022, reaching over 286 therapies.
- Focus on Drug Discovery and Development: The increasing focus on drug discovery is projected to accelerate the adoption of primary cell cultures, especially for testing efficacy and toxicity. These cells are likely to play a critical role in reducing reliance on animal testing by offering more reliable human-based cell models.
- Investments in Cancer Research: High investments in oncology research are expected to fuel the primary cell culture market, with these cultures being widely used in studying cancer cell behavior. Rising cancer incidence globally is anticipated to boost demand for advanced cellular models, increasing market growth.
- Growing Use of 3D Cell Cultures: The adoption of 3D cell cultures in research is estimated to enhance the relevance of primary cells, given their ability to replicate in vivo environments more effectively than traditional 2D cultures. This trend is expected to expand the application range of primary cell cultures in various research domains. According to VMR, 3D Cell Culture Market size was valued at USD 1.88 Billion in 2022 and is projected to reach USD 4.30 Billion in 2030, at a CAGR of 10.87% from 2023 to 2030.
Key Challenges:
- High Costs of Primary Cell Cultures: The high costs associated with primary cell culture processes are anticipated to restrain market growth, particularly in regions with limited research funding. The expense of procuring primary cells and maintaining specific growth conditions is expected to be a key challenge for market expansion.
- Technical Complexity and Variability: The technical complexity and inherent variability of primary cell cultures are likely to impede widespread adoption. This challenge is projected to limit scalability and reproducibility in large-scale research and industrial applications.
- Limited Availability of Primary Cells: The limited availability of high-quality primary cells is expected to hamper market growth, as sourcing human or animal tissues for these cultures remains difficult. Ethical concerns and regulatory restrictions around tissue procurement are anticipated to further restrain supply chains.
- Contamination Risks and Shorter lifespan: The higher risk of contamination and the shorter lifespan of primary cells compared to immortalized cell lines are likely to restrain the market. These limitations are expected to increase operational challenges for laboratories, reducing the efficiency of long-term studies.
Key Trends:
- Focus on Stem Cell Research: The rising emphasis on stem cell research is expected to significantly influence the primary cell culture market, given the need for high-quality primary cells in regenerative medicine. This trend is likely to enhance investment in research and development across the biotechnology and pharmaceutical sectors.
- Collaboration between Academia and Industry: Growing partnerships between academic institutions and biopharmaceutical companies are projected to boost the primary cell culture market. These collaborations are anticipated to drive innovation and expedite the commercialization of new cell-based therapies and research tools.
- Demand for Advanced Tissue Engineering: The high demand for advanced tissue engineering solutions is expected to drive the adoption of primary cell cultures in research and clinical applications. This trend is likely to open new avenues for developing organoids and bioengineered tissues, further expanding market potential.
Global Primary Cell Culture Market Regional Analysis
Here is a more detailed regional analysis of the global primary cell culture market:
North America:
- According to Verified Research Market Analyst, North America is anticipated to dominate the primary cell culture market due to the presence of advanced biotechnology and pharmaceutical industries.
- The United States is projected to lead the regional market, driven by increasing investments in research and development, as well as the growing focus on personalized medicine and drug discovery.
- A well-established healthcare infrastructure and strong academic-industry collaborations are expected to further support market growth in this region.
- The rising prevalence of chronic diseases such as cancer is also likely to drive demand for primary cell cultures in North American research institutions. The American Cancer Society estimates that there will be 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States in 2024.
Asia Pacific:
- The Asia Pacific region is estimated to experience the fastest growth in the primary cell culture market, driven by the rising investment in biotechnology and pharmaceutical sectors in countries such as China, Japan, and India.
- According to VMR, Biotechnology Market size was valued at USD 1023.92 Billion in 2023 and is projected to reach USD 2590.03 Billion by 2032, growing at a CAGR of 12.3% from 2026 to 2032.
- The increasing government initiatives to promote life sciences research, along with the expanding clinical research activities, are projected to propel market growth in the region.
- China's growing biotechnology industry, combined with its focus on innovation and healthcare, is anticipated to significantly boost the market for primary cell cultures.
- India is also likely to witness rapid growth, driven by a rising number of pharmaceutical companies and a growing focus on drug development and testing.
Global Primary Cell Culture Market: Segmentation Analysis
The Global Primary Cell Culture Market is Segmented on the basis of Product, Application, Cell Type, And Geography.
Primary Cell Culture Market, By Product
- Primary Cell
- Reagents And Supplements
- Media
Based on Product, the market is bifurcated into Primary Cell, Reagents And Supplements, and Media. The media segment is anticipated to hold the largest share of the primary cell culture market due to its critical role in supporting cell growth, proliferation, and differentiation. Media is projected to experience sustained demand as it is essential for maintaining the viability and functionality of primary cells throughout research and production processes.
Primary Cell Culture Market, By Application
- Vaccine Production
- Stem Cell Therapy
- Cancer Research
Based on Application, the Global Primary Cell Culture Market is divided into Vaccine Production, Stem Cell Therapy, and Cancer Research. The vaccine production segment is projected to hold the largest share of the primary cell culture market. The increasing use of primary cells in the development and production of vaccines is anticipated to drive this growth. Primary cells are widely used due to their ability to mimic natural human cell environments, which is crucial for creating vaccines that are safe and effective.
Primary Cell Culture Market, By Cell Type
Based on Cell Type, the market is segmented into Animal Cells and Human Cells. Human cells are anticipated to hold the largest share of the primary cell culture market, driven by their increasing application in drug discovery, personalized medicine, and cancer research. The demand for human primary cells is projected to rise due to their ability to provide more accurate and clinically relevant models for studying human physiology and disease.
Primary Cell Culture Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
- On the basis of Geography, the global primary cell culture market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America held the largest share of the primary cell culture market, driven by its advanced biotechnology and pharmaceutical industries. The region is projected to maintain its dominance due to the increasing focus on personalized medicine and rising investments in drug discovery and development.
Key Players
The "Global Primary Cell Culture Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Thermo Fisher Scientific, Merck KGaA, Lonza, Corning Incorporated, Danaher Corporation, GE Healthcare, PromoCell GmbH, American Type Culture Collection, FUJIFILM Irvine Scientific, MatTek Ltd, Axol Bioscience Ltd, STEMCELL Technologies Inc, Cell Biologics, ZenBio, ScienCell Research Laboratories, and PPA Research Group. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Latest Developments
- In March 2024, Lonza announced a collaboration with a renowned biopharmaceutical company to develop a new cell culture medium tailored exclusively for breakthrough cell therapy.
- In February 2024, Thermo Fisher Scientific introduced a new line of cryopreserved primary human hepatocytes, seeking to give researchers with a more consistent and trustworthy source of these cells for drug discovery applications.
- In February 2024, Corning Incorporated expanded its portfolio of Transwell(R) co-culture devices, which are intended to increase the efficiency and accuracy of cell-based assays used in drug development.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL PRIMARY CELL CULTURE MARKET
- 1.1 Introduction of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
4 GLOBAL PRIMARY CELL CULTURE MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
5 GLOBAL PRIMARY CELL CULTURE MARKET, BY PRODUCT
- 5.1 Overview
- 5.2 Primary Cell
- 5.3 Reagents And Supplements
- 5.4 Media
6 GLOBAL PRIMARY CELL CULTURE MARKET, BY APPLICATION
- 6.1 Overview
- 6.2 Vaccine Production
- 6.3 Stem Cell Therapy
- 6.4 Cancer Research
- 6.5 Others
7 GLOBAL PRIMARY CELL CULTURE MARKET, BY CELL TYPE
- 7.1 Overview
- 7.2 Animal Cells
- 7.3 Human Cells
8 GLOBAL PRIMARY CELL CULTURE MARKET, BY GEOGRAPHY
- 8.1 Overview
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
- 8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa
9 GLOBAL PRIMARY CELL CULTURE MARKET COMPETITIVE LANDSCAPE
- 9.1 Overview
- 9.2 Company Market Ranking
- 9.3 Key Development Strategies
10 COMPANY PROFILES
- 10.1 Thermo Fisher Scientific Inc.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
- 10.2 Lonza
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
- 10.3 Merck KGaA
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
- 10.4 Axol Bioscience Ltd
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
- 10.5 GE Healthcare
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
- 10.6 STEMCELL Technologies Inc
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
- 10.7 Cell Biologics
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
- 10.8 ZenBio
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
- 10.9 ScienCell Research Laboratories
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
- 10.10 PPA Research Group
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
11 KEY DEVELOPMENTS
- 11.1 Product Launches/Developments
- 11.2 Mergers and Acquisitions
- 11.3 Business Expansions
- 11.4 Partnerships and Collaborations
12 Appendix
